The turnover for basic pharmaceutical products and pharmaceutical preparations in Italy has shown a general upward trend from 2013 to 2023, increasing from 26.56 billion euros to 28.28 billion euros. However, the market demonstrated volatility with a notable dip from 2013 to 2014, followed by fluctuations and moderate growth. The year-on-year changes varied significantly, indicating periods of both decline and growth.
In the most recent years, the turnover grew at a modest pace, with a 0.82% increase in 2023. The compound annual growth rate (CAGR) for the last five years shows an insignificant average annual increase of 0.087%. The forecasted data suggest continued moderate growth, with the turnover expected to reach 29.39 billion euros by 2028, driven by a five-year CAGR of 0.61% and a total growth rate of 3.11% over the forecast period.
Future trends to watch for in the pharmaceutical sector in Italy include the impact of emerging biotech innovations, regulatory changes, the focus on personalized medicine, and the ongoing effects of global health challenges. Stakeholders should stay informed about technological advancements and policy shifts that may influence market dynamics.
